IndiaTickerNorris Medicines Ltd - 524414 - Certificate Under Reg. 74 (5) Of SEBI (DP) Regulations, 2018BSE · exchange filing · pdf
Source filing Company dossier
Norris Medicines
BSE:NORRIS · ISIN INE744C01029
- Close
- Unavailable Date unavailable
- Daily change
- N/A Exchange close
- Evidence state
- Building 0/0 checks
Norris Medicines
Filings
Preserved evidence
40 recent eventsPrimary-source filing timeline
Norris Medicines Ltd - 524414 - Closure of Trading WindowBSE · exchange filing · pdf
Source filing Norris Medicines Ltd - 524414 - Outcome Of Board Meeting Held Today I.E. 30Th May, 2026.BSE · financial results · pdf
Source filing Norris Medicines Ltd - 524414 - Announcement under Regulation 30 (LODR)-Change in ManagementBSE · exchange filing · pdf
Source filing Norris Medicines Ltd - 524414 - Board Meeting Outcome for Outcome Of Board Meeting Held Today I.E. 30Th May, 2026.BSE · exchange filing · pdf
Source filing Norris Medicines Ltd - 524414 - Board Meeting Intimation for Intimation Under Regulation 29 Of SEBI (Listing Obligation And Disclosure Requirements), 2015 For Holding Board Meeting For Approval Of Audited Financial Results For The Quarter And Year Ended March 31, 2026 And Other Matters.BSE · financial results · pdf
Source filing Norris Medicines Ltd - 524414 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018BSE · exchange filing · pdf
Source filing Norris Medicines Ltd - 524414 - Closure of Trading WindowBSE · exchange filing · pdf
Source filing Norris Medicines Ltd - 524414 - Board Meeting Outcome for Outcome Of The Board Meeting Held On 14Th February, 2026 Pursuant To Regulation 30 And 33 Of The SEBI (Listing Obligation And Disclosure Requirements) Regulations, 2015.BSE · exchange filing · pdf
Source filing Norris Medicines Ltd - 524414 - Outcome Of The Board Meeting Held On 14Th February, 2026 Pursuant To Regulation 30 And 33 Of The SEBI (Listing Obligation And Disclosure Requirements) Regulations, 2015.BSE · financial results · pdf
Source filing Norris Medicines Ltd - 524414 - Intimation Under Regulation 30 Of SEBI (LODR) Regulations, 2015 - Closure Of Case ID 223728 For Reclassification Of Promoter.BSE · exchange filing · pdf
Source filing Norris Medicines Ltd - 524414 - Board Meeting Intimation for Intimation Under Regulation 29 Of SEBI Listing Obligation And Disclosure Requirements, 2015 For Holding Board Meeting For Approval Of Un-Audited Financial Results For The Quarter And Nine Months Ended December 31St, 2025 And Other Matters.BSE · financial results · pdf
Source filing Norris Medicines Ltd - 524414 - Announcement under Regulation 30 (LODR)-Change in ManagementBSE · exchange filing · pdf
Source filing Norris Medicines Ltd - 524414 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018BSE · exchange filing · pdf
Source filing Norris Medicines Ltd - 524414 - Closure of Trading WindowBSE · exchange filing · pdf
Source filing Norris Medicines Ltd - 524414 - Announcement under Regulation 30 (LODR)-Resignation of DirectorBSE · exchange filing · pdf
Source filing Norris Medicines Ltd - 524414 - Intimation Regarding Completion Of NAFDAC Audit (Nigeria) Of Norris Medicines Limited.BSE · exchange filing · pdf
Source filing Norris Medicines Ltd - 524414 - Announcement under Regulation 30 (LODR)-Award_of_Order_Receipt_of_OrderBSE · exchange filing · pdf
Source filing Norris Medicines Ltd - 524414 - Board Meeting Outcome for Outcome Of Board Meeting Held Today I.E. Friday, November 14, 2025BSE · exchange filing · pdf
Source filing Norris Medicines Ltd - 524414 - Board Meeting Intimation for Intimation Under Regulation 29 Of SEBI Listing Obligation And Disclosure Requirements, 2015 For Holding Board Meeting For Approval Of Un-Audited Financial Results For The Quarter Ended September 30Th, 2025 And Other Matters.BSE · financial results · pdf
Source filing Norris Medicines Ltd - 524414 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018BSE · exchange filing · pdf
Source filing Norris Medicines Ltd - 524414 - Shareholder Meeting / Postal Ballot-Outcome of AGMBSE · exchange filing · pdf
Source filing Norris Medicines Ltd - 524414 - Voting Results For 34Th AGM.BSE · exchange filing · pdf
Source filing Norris Medicines Ltd - 524414 - Proceedings Of The 34Th Annual General Meeting Of Norris Medicines Limited Held For The Financial Year 2024-2025 On September 29Th, 2025.BSE · exchange filing · pdf
Source filing Norris Medicines Ltd - 524414 - Shareholder Meeting / Postal Ballot-Scrutinizer''s ReportBSE · exchange filing · pdf
Source filing Norris Medicines Ltd - 524414 - Closure of Trading WindowBSE · exchange filing · pdf
Source filing Norris Medicines Ltd - 524414 - Announcement under Regulation 30 (LODR)-Newspaper PublicationBSE · exchange filing · pdf
Source filing Norris Medicines Ltd - 524414 - Notice Of 34Th Annual General Meeting Of The Company.BSE · exchange filing · pdf
Source filing Norris Medicines Ltd - 524414 - Reg. 34 (1) Annual Report.BSE · annual report · pdf
Source filing Norris Medicines Ltd - 524414 - Letter To Shareholders, In Terms Of Regulation 36(1)(B) Of The SEBI Listing Regulations.BSE · exchange filing · pdf
Source filing Norris Medicines Ltd - 524414 - Intimation Of Cutoff Date For Remote E-Voting And Closure Of Register Of Members & Share Transfer Books At 34Th Annual General Meeting.BSE · exchange filing · pdf
Source filing Norris Medicines Ltd - 524414 - Announcement under Regulation 30 (LODR)-Change in ManagementBSE · exchange filing · pdf
Source filing Norris Medicines Ltd - 524414 - Board Meeting Outcome for Outcome Of Board Meeting Held On Monday, 01St September, 2025 Pursuant To Regulation 30 Of The SEBI (Listing Obligation And Disclosure Requirements) Regulations, 2015.BSE · exchange filing · pdf
Source filing Norris Medicines Ltd - 524414 - Board Meeting Outcome for Outcome Of Board Meeting Held On Thursday, 14Th August 2025 Pursuant To Regulation 30 And Regulation 33 Of The SEBI (Listing Obligation And Disclosure Requirements) Regulations, 2015.BSE · exchange filing · pdf
Source filing Norris Medicines Ltd - 524414 - Outcome Of Board Meeting Held On Thursday, 14Th August 2025 Pursuant To Regulation 30 And Regulation 33 Of The SEBI (Listing Obligation And Disclosure Requirements) Regulations, 2015.BSE · financial results · pdf
Source filing Norris Medicines Ltd - 524414 - Board Meeting Intimation for Intimation Under Regulation 29 Of SEBI Listing Obligation And Disclosure Requirements, 2015 For Holding Board Meeting For Approval Of Un-Audited Financial Results For The Quarter Ended June 30Th, 2025 And Other Matters.BSE · financial results · pdf
Source filing Norris Medicines Ltd - 524414 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018BSE · exchange filing · pdf
Source filing Norris Medicines Ltd - 524414 - Closure of Trading WindowBSE · exchange filing · pdf
Source filing Norris Medicines Ltd - 524414 - Board Meeting Outcome for Outcome Of The Board Meeting Held On May 28, 2025_Pursuant To Regulation 30 And Regulation 33 Of The SEBI (Listing Obligation And Disclosure Requirements) Regulations, 2015.BSE · exchange filing · pdf
Source filing Norris Medicines Ltd - 524414 - Outcome Of The Board Meeting Held On May 28, 2025_Pursuant To Regulation 30 And Regulation 33 Of The SEBI (Listing Obligation And Disclosure Requirements) Regulations, 2015.BSE · financial results · pdf
Source filing